Research & Development
Browse our research documents and publications, view our product pipeline and learn more about our research partners.
Reports, publications, and papers
Browse relevant documents to see the insights and thought leadership that we’ve spear headed over the years.
Patient-Led Care
How Patient Initiated Follow-Up (PIFU) Improves NHS Patient Outcomes in Long-Term Conditions
In this article, we discuss patient initiated follow-up (PIFU), the role remote monitoring plays and highlight 6 major benefits of implementing PIFU across the...
Evaluation of the My Arthritis App Digital Therapeutic
We have examined the lived experience of IA patients through 1-1 interviews, a combined Ampersand Health x NRAS workshop, literature review and through...
Support programme improves patients with IBD acceptance of and ability to cope with chronic symptoms
Ampersand’s digitally delivered 8-week support programme included live and guided access to support from a Clinical Psychologist and Health Coach, peer...
Patient Voices Podcast Episode 5
Our guests for episode 5 are Clive McIntyre and Dr Yeliz Prior who both share their powerful perspectives living with chronic inflammatory conditions and...
Patient Voices Podcast Episode 4
Our fourth guest on The Patient Voices Podcast is James Amos, an active young man, who spent many years running his own gym studio, working as a personal...
Patient Voices Podcast Episode 3
As part of our Patient Voices podcast series, we spoke to Teresa Shakespeare-Smith and Sally Dickinson.
Patient Voices Podcast Episode 2
As part of our podcast series, we spoke to Heather Savage and Anisha Gangotra. The conversation is captured in this blog.
Patient Voices Podcast Episode 1
We want to champion the experiences and opinions of the most important members of the healthcare ecosystem, patients. This week, we speak to Katy.
Patient Voices Podcast Launch – August 2021
We've launched Ampersand's Patient Voices Podcast: Experiences and expertise from the Ampersand community.
My IBD Care Service Evaluation at King’s College Hospital & The Royal London
In 2019, we were awarded an InnovateUK grant, which has enabled us to conduct this study, comprising over 300 adults across two large London centres (Barts...
Our HealthSuite can help manage a range of inflammatory conditions
Our research and development focuses on the full breadth of inflammatory and immuno-mediated conditions, enabling us to build an exciting roadmap of digital medicines.
Neuroendocrine Tumours
Currently, an observational trial is underway that is looking into the effectiveness of using a mobile application to collect Patient Reported Outcome data of those receiving treatment for Neuroendocrine Tumours.
This study is being conducted by King's College Hospital, along with a national charity and a major pharmaceutical company. Individuals who live with Neuroendocrine Tumours live a lower quality of life due to their condition. We are exploring the role digital therapeutics could play to alleviate treatment burden and improve clinical coordination to help patients gain a better quality of life.
Sickle Cell Disease
A leading NHS Trust and The Health Foundation are researching how our My Blood app can improve the process of collecting information from patients to avoid unnecessary trips to the hospital.
The My Blood app helps patients recieve remote care and could alleviate treatment burden, leading to benefits for both clinicians and patients.
Partner hospitals
Our app content is co-created with leading experts from 2 London hospitals.
NHS - Barts Health & King's College Hospital
We are partnered with the NHS, the world’s largest public health provider.
Our partnership with the NHS has allowed us to perform significant research and gain invaluable insights into the conditions that we focus on.
National Charities
We have partnered with national charities, such as Crohn’s and Colitis UK.
Our partnerships with national charities allow us to gain important insights into the experiences of the communities we work with.
NICE
Our platform has been assessed and approved by NICE, The National Institute for Health and Care Excellence.
Innovate UK
Our innovation has been funded by competitive grants from Innovate UK.
MHRA
Our platform is regulated by the Medicines and Healthcare Products Regulatory Agency.
ORCHA
Our app received the top rating by ORCHA, who are world leaders in health app evaluations.